Official AMFI data
Arthkar

Listed equity

Suraksha Diagnostic

NSE: SURAKSHABSE: 544293M-cap ₹1.4K Cr7 mutual funds hold this
268.951.50(+0.55%)

EOD close · 3 Jul 2026

breakdownaccumulation +21

Price is under pressure — 19% off its 52-week high — but delivery data shows buyers quietly stepping in. Weak chart, strong hands.

52W low ₹224.1052W high ₹333.65

Now at 41% of its 52-week range

Since listing

-34.7%

Recently listed — not enough history for 1-year returns yet.

Phase indicator

breakdown-19.4% from 52w high

Below 200-day MA — long-term trend negative.

1M
-6.0%
3M
+11.6%
1Y
-15.4%

Delivery conviction

accumulationscore +21
Delivery vs 20-day avg1.36x

Lifetime story

Suraksha Diagnostic is up 20.0% from its lifetime low of 224.10 on 30 Mar 2026. ₹10,000 invested then would be worth 12,001 today (101.7% CAGR over 0.3 years). Lifetime high of 449.00 was set on 6 Dec 2024 (currently -40.1% below).

Fundamentals

Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.

55% cheaper than industry(Industry P/E 92.5)
StandaloneConsolidated
P/E (TTM)41.7144.14
P/B5.695.81
Price / Cash flow19.2919.29
Dividend yield0.18%0.18%
Book value / share47.96 ₹47.01 ₹
EPS (TTM)6.54 ₹6.18 ₹
Market cap
₹1.4K Cr
52W high
₹333.65
16 Sept 2025
52W low
₹224.10
30 Mar 2026

Returns ladder

1W
+0.1%
1M
-6.0%
3M
+11.6%
6M
-1.3%
YTD
+1.7%
1Y
-15.4%
3Y
5Y
10Y
Since listing
-34.7%